EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effectiveness and Safety of STYLAGE® L Lidocaine in the Treatment of Nasolabial Folds (NICE Study): A Randomized, Double-Blind, Split-Face Controlled Study

Sophie Converset-Viethel, Magdalena Dobosz, Martine Baspeyras, Kamila Skretkowicz-Szarmach, Kai-Uwe Schlaudraff

Aesthetic Plastic Surgery · 2025

DOI: 10.1007/s00266-025-05105-2 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Aesthetic Plastic Surgery, 2025. Verfasst von Sophie Converset-Viethel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Private Aesthetic Surgery Practice, Palais de Flore, 10 Boulevard Jules Favre, 69006, Lyon, France. drconverset@gmail.com. Hauptthemen laut MEDLINE: Nasolabial Fold, Lidocaine, Skin Aging, Dermal Fillers. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Laboratoires VIVACY.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prominent nasolabial folds (NLFs) are a typical manifestation of aging. Hyaluronic acid (HA)-based injectable fillers are commonly used for correction. The NICE Study primarily evaluated non-inferiority of STYLAGE ® L Lidocaine (STYL-L), a cross-linked HA filler with lidocaine, versus the similar product Juvéderm ® ULTRA 3 (JUV-3) in correcting moderate to severe NLFs.

Methods

This was a double-blind, randomized, controlled, within-subject (split-face) study with 12 months follow-up. The primary endpoint was mean change in Wrinkle Severity Rating Scale (WSRS) score from baseline to 6 months after treatment initiation. Secondary endpoints included differences in NLF depth using interference fringe projection profilometry, Global Aesthetic Improvement Scale (GAIS), subject satisfaction, pain during injection, and tolerance.

Results

Of the 50 subjects randomized, 47 were analyzed. In the primary endpoint analysis, non-inferiority of STYL-L to JUV-3 was demonstrated as the upper limit of the 95% confidence interval (CI) was inferior to 0.5 (difference [95% CI] in WSRS change from baseline at 6 months was 0.11 [−0.07; 0.28]). NLF average depth was similarly reduced with STYL-L and JUV-3 at 1 month (adjusted mean [standard error] decrease of 0.049 [0.003] mm and 0.049 [0.004] mm, respectively), and generally maintained. Both evaluators and subjects considered NLFs improved, with all or almost all subjects classed as GAIS responders with both devices throughout the study. Overall subject satisfaction was high. Pain ratings were low. Both devices were well tolerated.

Conclusions

Non-inferiority of STYL-L versus JUV-3 in improving NLFs was demonstrated. Results up to 12 months suggest comparable effectiveness and safety profiles. Level of Evidence I This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nasolabial FoldLidocaineSkin AgingDermal FillersHyaluronic AcidCosmetic TechniquesAnesthetics, LocalHumansDouble-Blind MethodFemaleMiddle AgedTreatment OutcomeMaleAdultPatient SatisfactionFollow-Up StudiesEstheticsRejuvenation

Stichwörter der Autor:innen

Crossed-linked hyaluronic acidDermal fillerLidocaineNasolabial fold treatmentRandomized controlled trial (RCT)Stylage

Substanzen

LidocaineDermal FillersHyaluronic AcidAnesthetics, Local

Autor:innen und Institutionen

  • Private Aesthetic Surgery Practice, Palais de Flore, 10 Boulevard Jules Favre, 69006, Lyon, France. drconverset@gmail.com.
  • Private Dermatology Practice, Partyzantow 14/102, 80-254, Gdansk, Poland.
  • Private Dermatology Practice, 45, Avenue Bel Air, 33200, Bordeaux, France.
  • Private Dermatology Practice, Generala Augusta Emila Fieldorfa 21, 80-041, Gdansk, Poland.
  • Private Aesthetic Surgery Practice, Concept-Clinic, 24 Boulevard des Philosophes, Geneva, Switzerland.

Förderung

  • Laboratoires VIVACY

Zitieren

APA

Converset-Viethel, S., Dobosz, M., Baspeyras, M., Skretkowicz-Szarmach, K., & Schlaudraff, K. U. (2025). Effectiveness and Safety of STYLAGE® L Lidocaine in the Treatment of Nasolabial Folds (NICE Study): A Randomized, Double-Blind, Split-Face Controlled Study. Aesthetic Plastic Surgery. https://doi.org/10.1007/s00266-025-05105-2

Vancouver

Converset-Viethel S, Dobosz M, Baspeyras M, Skretkowicz-Szarmach K, Schlaudraff KU. Effectiveness and Safety of STYLAGE® L Lidocaine in the Treatment of Nasolabial Folds (NICE Study): A Randomized, Double-Blind, Split-Face Controlled Study. Aesthetic Plastic Surgery. 2025. doi:10.1007/s00266-025-05105-2

BibTeX
@article{ConversetViethel2025,
  author = {Converset-Viethel, Sophie and Dobosz, Magdalena and Baspeyras, Martine and Skretkowicz-Szarmach, Kamila and Schlaudraff, Kai-Uwe},
  title = {Effectiveness and Safety of STYLAGE® L Lidocaine in the Treatment of Nasolabial Folds (NICE Study): A Randomized, Double-Blind, Split-Face Controlled Study},
  journal = {Aesthetic Plastic Surgery},
  year = {2025},
  doi = {10.1007/s00266-025-05105-2}
}
Kostenlos starten →